290 related articles for article (PubMed ID: 32004567)
21. No Additional Benefit of Combining Fractional Carbon Dioxide Laser With Narrow-Band Ultraviolet B Phototherapy for Vitiligo: A Randomized Prospective Study With Half-Body Side Comparison.
Eşme P; Gür Aksoy G; Elçin G
Dermatol Surg; 2019 Dec; 45(12):1627-1634. PubMed ID: 30829772
[TBL] [Abstract][Full Text] [Related]
22. Tacrolimus (FK506) ointment combined with Nb-UVB could activate both hair follicle (HF) and dermal melanocyte precursors in vitiligo: the first histopathological and clinical study.
Gauthier Y; Almasi-Nasrabadi M; Cario-André M; Pain C; Rakhshan A; Ghalamkarpour F
Arch Dermatol Res; 2021 Jul; 313(5):383-388. PubMed ID: 32303824
[TBL] [Abstract][Full Text] [Related]
23. Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with psoriatic arthritis and current skin involvement: a phase III, randomised, controlled trial (PALACE 3).
Edwards CJ; Blanco FJ; Crowley J; Birbara CA; Jaworski J; Aelion J; Stevens RM; Vessey A; Zhan X; Bird P
Ann Rheum Dis; 2016 Jun; 75(6):1065-73. PubMed ID: 26792812
[TBL] [Abstract][Full Text] [Related]
24. Triple combination therapy of narrowband ultraviolet B, fractional carbon dioxide laser and topical bimatoprost 0.01% for non-segmental vitiligo on non-facial areas: A randomized half-body, double-blind, placebo-controlled, comparative study.
Kanokrungsee S; Khunkhet S; Rojhirunsakool S; Thadvibun K; Sahaspot T
Dermatol Ther; 2022 Jan; 35(1):e15198. PubMed ID: 34750933
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of narrow band UVB with or without OMP in stabilization of vitiligo activity in skin photo-types (III-V): A double-blind, randomized, placebo-controlled, prospective, multicenter study.
Esmat SM; El-Mofty M; Rasheed H; Mostafa WZ; Anbar TS; Abdallah M; Bassiouny D; Abdel-Halim D; Hegazy R; Eid AA; Nassar A; Abdel-Aziz RT; Fawzy MM; Gawdat HI; El Hawary M; Sany I; Shalaby S; Ragab N; Abdel-Gaber RM; Tawfik YM; El-Bassiouny M; El-Husseiny R; Attia MS; Farid C; Genedy RM; Mogawer RM
Photodermatol Photoimmunol Photomed; 2022 May; 38(3):277-287. PubMed ID: 34726808
[TBL] [Abstract][Full Text] [Related]
26. Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor, in patients with moderate to severe plaque psoriasis: Results of a phase III, randomized, controlled trial (Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis [ESTEEM] 1).
Papp K; Reich K; Leonardi CL; Kircik L; Chimenti S; Langley RG; Hu C; Stevens RM; Day RM; Gordon KB; Korman NJ; Griffiths CE
J Am Acad Dermatol; 2015 Jul; 73(1):37-49. PubMed ID: 26089047
[TBL] [Abstract][Full Text] [Related]
27. Comparison of efficacy and safety profile of topical calcipotriol ointment in combination with NB-UVB vs. NB-UVB alone in the treatment of vitiligo: a 24-week prospective right-left comparative clinical trial.
Khullar G; Kanwar AJ; Singh S; Parsad D
J Eur Acad Dermatol Venereol; 2015 May; 29(5):925-32. PubMed ID: 25220387
[TBL] [Abstract][Full Text] [Related]
28. A comparative interventional study of narrowband ultraviolet B alone and narrowband ultraviolet B in combination with microneedling in patients with stable vitiligo.
Kaur A; Barman KD; Sahoo B; Choudhary P
Photodermatol Photoimmunol Photomed; 2023 Jul; 39(4):357-363. PubMed ID: 36419200
[TBL] [Abstract][Full Text] [Related]
29. Combined treatment with fractional carbon dioxide laser, autologous platelet-rich plasma, and narrow band ultraviolet B for vitiligo in different body sites: A prospective, randomized comparative trial.
Abdelghani R; Ahmed NA; Darwish HM
J Cosmet Dermatol; 2018 Jun; 17(3):365-372. PubMed ID: 28834191
[TBL] [Abstract][Full Text] [Related]
30. Tacalcitol and narrow-band phototherapy in patients with vitiligo.
Leone G; Pacifico A; Iacovelli P; Paro Vidolin A; Picardo M
Clin Exp Dermatol; 2006 Mar; 31(2):200-5. PubMed ID: 16487090
[TBL] [Abstract][Full Text] [Related]
31. A comparative study of combined microneedling and narrowband ultraviolet B phototherapy versus their combination with topical latanoprost in the treatment of vitiligo.
Neinaa YME; Lotfy SS; Ghaly NR; Doghaim NN
Dermatol Ther; 2021 Mar; 34(2):e14813. PubMed ID: 33497514
[TBL] [Abstract][Full Text] [Related]
32. Study the effect of erbium:YAG laser plus topical 5-flurouracil in stable vitiligo resistant to NB-UVB phototherapy.
Doghaim NN; El-Tatawy RA; Ismail MA; Ali DAM; El Attar YA
J Cosmet Dermatol; 2020 Jan; 19(1):122-130. PubMed ID: 31571367
[TBL] [Abstract][Full Text] [Related]
33. Oral gliadin-protected superoxide dismutase in addition to phototherapy for treating non-segmental vitiligo: A 24-week prospective randomized placebo-controlled study.
Fontas E; Montaudié H; Passeron T
J Eur Acad Dermatol Venereol; 2021 Aug; 35(8):1725-1729. PubMed ID: 33931900
[TBL] [Abstract][Full Text] [Related]
34. Apremilast, an oral phosphodiesterase 4 inhibitor, in the treatment of Japanese patients with moderate to severe plaque psoriasis: Efficacy, safety and tolerability results from a phase 2b randomized controlled trial.
Ohtsuki M; Okubo Y; Komine M; Imafuku S; Day RM; Chen P; Petric R; Maroli A; Nemoto O
J Dermatol; 2017 Aug; 44(8):873-884. PubMed ID: 28391657
[TBL] [Abstract][Full Text] [Related]
35. Randomized clinical trial of combined therapy with oral α-lipoic acid and NB-UVB for nonsegmental stable vitiligo.
Sun Y; Guan X; Wang H; Zhang J; Gu H; Lu H; Yao Z; Chen X; Zeng F; Wu Y; Gao XH
Dermatol Ther; 2021 Jan; 34(1):e14610. PubMed ID: 33258534
[TBL] [Abstract][Full Text] [Related]
36. Feasibility, double-blind, randomised, placebo-controlled, multi-centre trial of hand-held NB-UVB phototherapy for the treatment of vitiligo at home (HI-Light trial: Home Intervention of Light therapy).
Eleftheriadou V; Thomas K; Ravenscroft J; Whitton M; Batchelor J; Williams H
Trials; 2014 Feb; 15():51. PubMed ID: 24507484
[TBL] [Abstract][Full Text] [Related]
37. Comparative efficacy between localized 308-nm excimer light and targeted 311-nm narrowband ultraviolet B phototherapy in vitiligo: A randomized, single-blind comparison study.
Poolsuwan P; Churee C; Pattamadilok B
Photodermatol Photoimmunol Photomed; 2021 Mar; 37(2):123-130. PubMed ID: 33047405
[TBL] [Abstract][Full Text] [Related]
38. Intrapatient comparison of 308-nm monochromatic excimer light and localized narrow-band UVB phototherapy in the treatment of vitiligo: a randomized controlled trial.
Verhaeghe E; Lodewick E; van Geel N; Lambert J
Dermatology; 2011; 223(4):343-8. PubMed ID: 22269666
[TBL] [Abstract][Full Text] [Related]
39. Apremilast and narrowband ultraviolet B combination therapy suppresses Th17 axis and promotes melanogenesis in vitiligo skin: a randomized, split-body, pilot study in skin types IV-VI.
Kim HJ; Del Duca E; Pavel AB; Singer GK; Abittan BJ; Chima MA; Kimmel G; Bares J; Baum D; Gagliotti M; Genece J; Chu J; Lebwohl MG; Guttman-Yassky E
Arch Dermatol Res; 2023 Mar; 315(2):215-221. PubMed ID: 35279741
[TBL] [Abstract][Full Text] [Related]
40. Effect of narrow-band ultraviolet B on the serum of 25-hydroxyvitamin D in vitiligo patients.
Ibrahim H; El Taieb M; El Gamel Z; El Saied AR
J Cosmet Dermatol; 2018 Oct; 17(5):911-916. PubMed ID: 29524288
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
